SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001213900-20-045274
Filing Date
2020-12-30
Accepted
2020-12-30 08:02:39
Documents
1
Period of Report
2020-09-30
Effectiveness Date
2020-12-30

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING ea132374-nt10k_rasnatherap.htm NT 10-K 16809
  Complete submission text file 0001213900-20-045274.txt   17965
Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: NT 10-K | Act: 34 | File No.: 333-191083 | Film No.: 201424091
SIC: 2834 Pharmaceutical Preparations